news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

news

Cancer centers are suffering major shortage of popular chemo drugs - Joggingvideo.com
17.8 C
New York
Thursday, June 13, 2024

Cancer centers are suffering major shortage of popular chemo drugs

CHARLOTTE, N.C. – Common cancer drugs are running short due to ongoing supply chain issues, forcing doctors to make tough decisions about treating patients., a new survey shows 

The National Comprehensive Cancer Network (NCCN) says 90% of cancer centers in the U.S. are affected by shortages of two main drugs. 

Doctors say this isn’t the first chemo shortage they’ve dealt with, but it might be one of the toughest ones yet. 

“Some of the facilities in the United States, we understand, actually have no Carboplatin or Cisplatin available,” said Dr. Robert W. Carlson, the CEO of the NCCN.

“I was worried, because I didn’t want this to be prolonged,” said Gail Lass, who is being treated for stage 2 lung cancer in Charlotte, North Carolina.

Lass needed Carboplatin, but her doctor didn’t have any and wasn’t sure if he’d be able to find it elsewhere. Eventually, her doctor arranged for her to get the chemo at a nearby hospital.

TWO NEW CANCER PILLS SHOW ‘UNPRECEDENTED’ RESULTS IN BOOSTING SURVIVAL RATES AND PREVENTING RECURRENCE

A graphic showing the shortage

A National Comprehensive Cancer Network survey of 27 U.S. cancer centers shows 93% have reported a shortage of Carboplatin, and 70% reported a shortage of Cisplatin. (Fox News)

It’s estimated that Cisplatin and other similar platinum-based drugs are prescribed for an estimated 10% to 20% of all cancer patients, according to the National Cancer Institute.

“It’s going to get worse before it gets better,” Carlson predicted.

DRUG SHORTAGES IN CANCER, ASTHMA, TRANSPLANT, BACTERIAL INFECTION TREATMENTS

CLICK HERE TO GET THE FOX NEWS APP

Carboplatin drug being labeled

Registered Pharmacy Technician Dawn Deslippe labels a dosage of Carboplatin for a cancer patient receiving treatment at Windsor Regional Hospital in Ontario, just across the border from Detroit, Michigan.   (Richard Lautens/Toronto Star via Getty Images)

“The FDA recognizes the potential impact that lack of availability of certain products may have on health care providers and patients,” the FDA said in a statement to Fox News. 

“While the agency does not manufacturer drugs and cannot require a pharmaceutical company to make a drug, make more of a drug, or change the distribution of a drug, the public should rest assured the FDA is working closely with numerous manufacturers and others in the supply chain to understand, mitigate and prevent or reduce the impact of intermittent or reduced availability of certain products.”

Related Articles

Stay Connected

1,520FansLike
4,561FollowersFollow
0FollowersFollow
- Advertisement -

Latest Articles